FDA PMA FDA Class 3 Approved 🇺🇸 United States

Excimer Laser System

PMA: P930016 · Supplement: S030 · Decision Jan 16, 2008
Classifications
1
FEI Numbers
9
Registration Numbers
10

Basic Information

Device Name
Excimer Laser System
Trade Name
STAR S4 IR EXCIMER LASER SYSTEM WITH VARIABLE SPOT SCANNING (VSS) WAVESCAN WAVEFRONT SYSTEM
PMA Number
P930016
Supplement Number
S030
Device Class
FDA Class 3
Product Code
LZS
Generic Name
Excimer laser system
Medical Specialty
Unknown
Advisory Committee
Ophthalmic
Decision
Approved
Decision Code
APPR
Decision Date
January 16, 2008
Date Received
November 21, 2007
Supplement Type
Real-Time Process
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR THE UPGRADE WAVESCAN WAVEFRONT SYSTEM SOFTWARE VERSION 3.90. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAMES STAR S4 IR EXCIMER LASER SYSTEM WITH VARIABLE SPOT SCANNING (VSS) WAVESCAN WAVEFRONT SYSTEM AND ARE INDICATED FOR WAVEFRONT-GUIDED (WRG) LASER ASSISTED IN SITU KERATOMILEUSIS (LASIK) TO ACHIEVE EYE OF PRESBYOPIC MYOPES: 1) 40 YEARS OR OLDER WHO MAY BENEFIT FROM INCREASED SPECTACLE INDEPENDENCE ACROSS A RANGE OF DISTANCES WITH USEFUL NEAR VISION; 2) WITH MYOPIC ASTIGMATISM UP TO -6.00 D MRSE, WITH CYLINDER UP TO -3.00 D, AND MINIMUM PRE-OPERATIVE MYOPIA IN THEIR NON-DOMINANT EYE AT LEAST AS GREAT AS THEIR TARGETED MYOPIA; 3) WITH DOCUMENTED EVIDENCE OF A CHANGE IN MANIFEST REFRACTION OF NO MORE THAN 0.50 D (IN BOTH CYLINDER AND SPHERE COMPONENTS) FOR AT LEAST ONE YEAR PRIOR TO THE DATE OF PREOPERATIVE EXAMINATION; AND 4) WITH A SUCCESSFUL PREOPERATIVE TRIAL OF MONOVISION OR HISTORY OF MONOVISION EXPERIENCE.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LZS Excimer Laser System